Mirati e Merck focarão o estudo combinado de adagrasibe/Keytruda em pacientes com câncer de pulmão
07 December 2022 - 7:30AM
Newspaper
/jornal/2022/12/mirati-e-merck-focarao-o-estudo-combinado-de-adagrasibe-keytruda-em-pacientes-com-cancer-de-pulmao/
Mirati Therapeutics (BOV:M2RT34)
Historical Stock Chart
From Aug 2024 to Sep 2024
Mirati Therapeutics (BOV:M2RT34)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Mirati Therapeutics Inc (Brazil Bovespa Exchange): 0 recent articles
More News Articles